Febutaz 80 Tablet contains Febuxostat 80mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks, tophi formation, and kidney complications associated with elevated uric acid. Febutaz 80 is typically prescribed for adults who have not responded adequately to other urate-lowering therapies or who are intolerant to allopurinol. The tablet should be taken orally, usually once daily, with or without food, as directed by a healthcare professional. Patients are advised to maintain adequate hydration during treatment to minimize the risk of kidney stones. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities; therefore, periodic monitoring of liver function tests is recommended. Febutaz 80 is contraindicated in patients with severe liver impairment or hypersensitivity to Febuxostat. It is essential to inform the physician about any other medications being taken to avoid potential drug interactions. Proper adherence to the prescribed dosage and regular follow-up can effectively manage uric acid levels and reduce gout-related complications.